Sana Biotechnology (SANA) Interest & Investment Income (2020 - 2026)
Sana Biotechnology (SANA) reported Interest & Investment Income of -$30000.0 for Q1 2026, down 114.29% on a YoY basis from $210000.0 in Q1 2025, and down 528.57% sequentially from $7000.0 in Q4 2025.
Sana Biotechnology (SANA) Interest & Investment Income (2020 - 2026) Analysis & Trends
Sana Biotechnology (SANA) has 7 years of Interest & Investment Income data on file, last reported at -$30000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 114.29% year-over-year to -$30000.0; the trailing twelve-month figure through Mar 2026 stood at -$2000.0 (down 113.33% YoY), and the FY2025 full-year result was $14000.0, down 81.08% from the prior year.
- Interest & Investment Income declined to -$30000.0 in Q1 2026, from $7000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $2.2 million in Q1 2023 to a low of -$3.8 million in Q1 2022.
- A 5-year average of $85250.0 and a median of $14000.0 in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income slumped 14738.46% in 2022 and soared 1089.55% in 2023, its largest moves.
- Tracing SANA's Interest & Investment Income over 5 years: stood at $2.1 million in 2022, then sank by 93.2% to $142000.0 in 2023, then sank by 128.17% to -$40000.0 in 2024, then surged by 117.5% to $7000.0 in 2025, then slumped by 528.57% to -$30000.0 in 2026.
- Business Quant data shows SANA's Interest & Investment Income at -$30000.0 in Q1 2026, $7000.0 in Q4 2025, and $21000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Sana Biotechnology | 923.31 Mn | 923.31 Mn | - | -30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Mar 31, 2025 | -14,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Sep 30, 2024 | 73,000.00 |
| Jun 30, 2024 | -4,000.00 |
| Mar 31, 2024 | 45,000.00 |
| Dec 31, 2023 | 142,000.00 |
| Sep 30, 2023 | 663,000.00 |
| Jun 30, 2023 | 1.27 Mn |
| Mar 31, 2023 | 2.19 Mn |
| Dec 31, 2022 | 2.09 Mn |
| Sep 30, 2022 | -67,000.00 |
| Jun 30, 2022 | -1.18 Mn |
| Mar 31, 2022 | -3.81 Mn |
| Dec 31, 2021 | -1.28 Mn |
| Sep 30, 2021 | -95,000.00 |
| Jun 30, 2021 | -43,000.00 |
| Mar 31, 2021 | 26,000.00 |